B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are comparably useful for disease monitoring in heart failure
Authors:
- Angelika Hammerer-LercherAHAngelika Hammerer-Lercher
- 1 January 2006
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 106 (3) , 415-417
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Bedside B-Type Natriuretic Peptide and Functional Capacity in Chronic Heart FailureEuropean Journal of Heart Failure, 2003
- Effects of the angiotensin‐converting enzyme inhibitor alacepril on exercise capacity and neurohormonal factors in patients with mild‐to‐moderate heart failureClinical and Experimental Pharmacology and Physiology, 2002
- B-type natriuretic peptide as a marker of the effects of enalapril in patients with heart failureThe American Journal of Medicine, 2002
- The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failureJournal of Cardiac Failure, 2002
- Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failureJACC, 2001
- Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an immunoradiometric assay methodScandinavian Journal of Clinical and Laboratory Investigation, 2000
- Development of a novel, N-Terminal-proBNP (NT-proBNP) assay with a low detection limitScandinavian Journal of Clinical and Laboratory Investigation, 1999
- Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicineClinical Chemistry, 1993